Anti-EGFL7 Reference Antibody (parsatuzumab)
- Product Code: 140020
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in targeted cancer therapy, particularly in the treatment of solid tumors such as non-small cell lung cancer and colorectal cancer. It works by binding to EGFL7, a protein involved in blood vessel formation, thereby inhibiting tumor angiogenesis and reducing tumor growth. It has been investigated in clinical trials to enhance the effectiveness of chemotherapy and other anti-cancer agents by normalizing tumor vasculature and improving drug delivery.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | Ft50,976.37 |
+
-
|
Anti-EGFL7 Reference Antibody (parsatuzumab)
Used in targeted cancer therapy, particularly in the treatment of solid tumors such as non-small cell lung cancer and colorectal cancer. It works by binding to EGFL7, a protein involved in blood vessel formation, thereby inhibiting tumor angiogenesis and reducing tumor growth. It has been investigated in clinical trials to enhance the effectiveness of chemotherapy and other anti-cancer agents by normalizing tumor vasculature and improving drug delivery.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :